AzTrials
AzTrials

Postoperative PainPhase 2/3NCT01418807

Transumbilical Versus Transvaginal Specimen Retrieval at Minilaparoscopy

A Phase 2/3 study testing TRANSVAGINAL SPECIMEN EXTRACTION and TRANSUMBILICAL SPECIMEN EXTRACTION in people with Postoperative Pain and Patients Satisfaction, run by Università degli Studi dell'Insubria at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We hypothesise that pain at minilaparoscopy for gynecologic disease is reduced when transvaginal rather than transumbilical specimen extraction is accomplished. This would be due to the avoidance of a 10-mm port in the umbilicus. Read more about this study

Who is it for?
Any age, women only
What is being tested?
TRANSVAGINAL SPECIMEN EXTRACTION and TRANSUMBILICAL SPECIMEN EXTRACTION
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteItaly
Study dates
Jul 2011to Dec 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Adnexal Mass
  • Benign Gynecologic Condition
  • Laparoscopicb Surgery

Who cannot join

  • Obliteration Of The Douglas Pouch

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Department of Obstetrics and Gynecology Universita' Dell'Insubria

    Varese, 21100

Other trials in Italy

About this study

We hypothesise that pain at minilaparoscopy for gynecologic disease is reduced when transvaginal rather than transumbilical specimen extraction is accomplished. This would be due to the avoidance of a 10-mm port in the umbilicus. Visual analogue scale score of post-operative pain will be obtained and patients satisfaction will be asked at the 2-month postoperative visit.

Being tested
TRANSVAGINAL SPECIMEN EXTRACTION, TRANSUMBILICAL SPECIMEN EXTRACTION
Medical subject headings
Pain, Postoperative, Intraoperative Complications, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TRANSVAGINAL SPECIMEN EXTRACTIONProcedure or surgery

    Transvaginal specimen retrieval following posterior colpotomy

  • TRANSUMBILICAL SPECIMEN EXTRACTIONProcedure or surgery

    Transumbilical specimen retrieval following enlargement of the umbilical port

Study groups in NCT01418807
Study groupRoleWhat they receive
TRANSVAGINAL EXTRACTIONExperimentalNot described
Receives: Procedure: TRANSVAGINAL SPECIMEN EXTRACTION
TRANSUMBILICAL EXTRACTIONActive comparatorNot described
Receives: Procedure: TRANSUMBILICAL SPECIMEN EXTRACTION

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2011 (estimated)
  2. Study startJul 2011
  3. Primary completionDec 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01418807
Sponsor's protocol ID
mini-LPS Specimen extraction
Status last verified
Feb 2012
First submitted
16 Aug 2011
Last updated
24 Feb 2012
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing TRANSVAGINAL SPECIMEN EXTRACTION and TRANSUMBILICAL SPECIMEN EXTRACTION in people with Postoperative Pain and Patients Satisfaction, run by Università degli Studi dell'Insubria at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in